NO923548L - Hsv gd2 baculovirus-ekspresjonssystem - Google Patents

Hsv gd2 baculovirus-ekspresjonssystem

Info

Publication number
NO923548L
NO923548L NO92923548A NO923548A NO923548L NO 923548 L NO923548 L NO 923548L NO 92923548 A NO92923548 A NO 92923548A NO 923548 A NO923548 A NO 923548A NO 923548 L NO923548 L NO 923548L
Authority
NO
Norway
Prior art keywords
expression system
baculovirus expression
hsv
recombinant
glycoprotein formed
Prior art date
Application number
NO92923548A
Other languages
English (en)
Norwegian (no)
Other versions
NO923548D0 (no
Inventor
Victoria Ann Landolfi
Natalie Beth Figueroa
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO923548D0 publication Critical patent/NO923548D0/no
Publication of NO923548L publication Critical patent/NO923548L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92923548A 1991-09-13 1992-09-11 Hsv gd2 baculovirus-ekspresjonssystem NO923548L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75931091A 1991-09-13 1991-09-13

Publications (2)

Publication Number Publication Date
NO923548D0 NO923548D0 (no) 1992-09-11
NO923548L true NO923548L (no) 1993-03-15

Family

ID=25055183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923548A NO923548L (no) 1991-09-13 1992-09-11 Hsv gd2 baculovirus-ekspresjonssystem

Country Status (8)

Country Link
EP (1) EP0531728A1 (enExample)
JP (1) JPH05252965A (enExample)
AU (1) AU2355392A (enExample)
CA (1) CA2078087A1 (enExample)
FI (1) FI924080L (enExample)
IL (1) IL103130A0 (enExample)
NO (1) NO923548L (enExample)
TW (1) TW232710B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0796333A1 (en) * 1994-12-06 1997-09-24 Bruschettini S.R.L. Glycoproteins from herpes virus and vaccines containing them
KR100408817B1 (ko) * 1995-07-28 2004-02-25 주식회사 엘지생명과학 헤르페스심플렉스바이러스의당단백질을대량발현시키는동물세포주
US6821519B2 (en) 2000-06-29 2004-11-23 Corixa Corporation Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
US6537555B2 (en) 2000-06-29 2003-03-25 Corixa Corporation Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
DE60324678D1 (de) 2002-07-18 2008-12-24 Univ Washington N t-lymphozyten und damit identifizierte hsv-antigene
US20070269414A1 (en) 2003-11-04 2007-11-22 Shinji Okano Method for Producing Gene Transferred Denritic Cells
WO2010055900A1 (ja) 2008-11-14 2010-05-20 ディナベック株式会社 樹状細胞の製造方法

Also Published As

Publication number Publication date
FI924080A7 (fi) 1993-03-14
FI924080L (fi) 1993-03-14
JPH05252965A (ja) 1993-10-05
AU2355392A (en) 1993-03-18
FI924080A0 (fi) 1992-09-11
EP0531728A1 (en) 1993-03-17
TW232710B (enExample) 1994-10-21
NO923548D0 (no) 1992-09-11
CA2078087A1 (en) 1993-03-14
IL103130A0 (en) 1993-02-21

Similar Documents

Publication Publication Date Title
MY110086A (en) Herpes simplex virus vaccines comrpising glycoprotein d and 3d-mpl
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
AU591125B2 (en) Therapeutic nucleosides
DK77090A (da) Immunmodulerende azaspiraner
EP0541692A4 (en) Herpes simplex virus vp16 vaccines
BR9712366A (pt) Gene de gd2 do vírus do herpes simples hsv2 isolado, plasmídeo compreendendo o mesmo, e, processos de induzir, em indivíduo, uma resposta imune contra hsv2 gd2, de tratar um indíviduo que está infectado com hsv, e, de prevenir que um indivíduo fique infectado com hsv
TW362973B (en) Use of 2-anino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a composition having an antidepressant activity
NO931133L (no) Legemidler av polyhydroksymetylenderivater, fremgangsmaater for deres fremstilling og anvendelse
EP0175787A4 (en) RECOMBINANT gB-gD VACCINE AGAINST HERPES SIMPLEX.
NO923548L (no) Hsv gd2 baculovirus-ekspresjonssystem
DE69527294D1 (en) 4-[2-amino-6-(cyclopropylamino)-9h-pyrin-9-yl]-2-cyclopenten-1-methanol-succinat als antivirales mittel
NZ235316A (en) Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection
NO174834C (no) Fremgangsmåte til fremstilling av farmasöytisk kombinasjonspreparat
EP0289550A4 (en) Vaccine for the treatment of HSV.
BR9604853A (pt) Vacinas contra chlamydia
AU6383296A (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
AU8545391A (en) The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses
GR3005736T3 (enExample)
NO179855C (no) Fremgangsmåte for fremstilling av et legemiddel
NZ256246A (en) Serine leukocyte protease inhibitor, recombinant preparation thereof, and treatment of a retroviral infection
MY111746A (en) Therapeutic nucleosides.
ATE112489T1 (de) Extrakte von acanthospermum hispidum-pflanzen.
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
AU2396900A (en) Treatment and prevention of hiv and other viral infections
FI930519A0 (fi) Peptider foer blokering av infektioner orsakade av hiv-virus samt foerfarande foer deras anvaendnig